Related Experiment Video
Updated: May 28, 2026

09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Treatment selection for uveal melanoma.
1Ocular Oncology Service, Royal Liverpool University Hospital, Liverpool, UK.
Developments in Ophthalmology
|November 2, 2011
Summary
Personalized treatment selection for uveal melanomas involves tailoring radiotherapy, phototherapy, and resection based on tumor characteristics and patient preferences. Challenges include limited resources and evidence, necessitating further research for optimal patient care.
Area of Science:
- Ophthalmology
- Oncology
- Medical Treatment
Background:
- Uveal melanomas require tailored treatment strategies considering tumor size, location, and patient-specific factors.
- Treatment selection is complicated by resource limitations, incomplete patient data (e.g., genetic tumor type), and insufficient scientific evidence.
Purpose of the Study:
- To outline a personalized approach for selecting treatments for various uveal melanoma types.
- To describe patient interaction methods for optimal treatment choice.
- To discuss challenges and suggest future research directions in uveal melanoma care.
Main Methods:
- Case-based discussion of treatment selection for small, large, juxtapapillary, ciliary, and iridal melanomas.
- Description of patient-centered communication strategies.
- Analysis of current challenges and limitations in uveal melanoma management.
Main Results:
- A framework for tailoring radiotherapy, phototherapy, and local resection based on tumor characteristics.
- Emphasis on patient-physician dialogue for personalized treatment decisions.
- Identification of key areas for improvement in uveal melanoma patient care.
Conclusions:
- Personalized treatment selection is crucial for uveal melanoma management, balancing tumor and patient factors.
- Addressing resource limitations and enhancing scientific evidence are vital for future progress.
- Further research is needed to refine decision-making processes and improve patient outcomes.
Related Concept Videos
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
